TY - JOUR T1 - Primary hepatic follicular lymphoma 5 years post sustained virological response from hepatitis C viral infection JF - Journal of Clinical Pathology JO - J Clin Pathol SP - e3 LP - e3 DO - 10.1136/jclinpath-2020-206469 VL - 74 IS - 2 AU - Tomonari Shimagaki AU - Takashi Maeda AU - Nao Kinjo AU - Daisuke Imai AU - Huanlin Wang AU - Nao Ohama AU - Keitaro Edahiro AU - Makoto Edagawa AU - Tomoyoshi Takenaka AU - Takahiro Ohmine AU - Shohei Yamaguchi AU - Kozo Konishi AU - Shinichi Tsutsui AU - Hiroyuki Matsuda Y1 - 2021/02/01 UR - http://jcp.bmj.com/content/74/2/e3.abstract N2 - A 72-year-old man who was treated with a combination of simeprevir with peginterferon and ribavirin for hepatitis C virus (HCV) infection (genotype 1b) 5 years ago and has been treated as sustained virological response, was found to have a 2.6 cm tumourous lesion in the medial segment of the liver. He underwent a left hepatic lobectomy with a diagnosis of suspected hepatocellular carcinoma. The patient remained stable in follow-up CT every 3 months for more than 14 months.Hepatocellular carcinoma.Mantle cell lymphoma.Mucosa-associated lymphoid tissue lymphoma.Primary diffuse large B-cell lymphoma.Primary hepatic follicular lymphoma.Primary hepatic lymphoma (PHL) is a rare disease, representing 0.4% of extranodal non-Hodgkin’s lymphoma.1 The most common histological type is reported to be diffuse large B-cell lymphoma. … ER -